BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17395974)

  • 1. p53 family proteins in thyroid cancer.
    Malaguarnera R; Vella V; Vigneri R; Frasca F
    Endocr Relat Cancer; 2007 Mar; 14(1):43-60. PubMed ID: 17395974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
    Paull AC; Whikehart DR
    Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
    Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
    Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73 tumor-suppressor activity is impaired in human thyroid cancer.
    Frasca F; Vella V; Aloisi A; Mandarino A; Mazzon E; Vigneri R; Vigneri P
    Cancer Res; 2003 Sep; 63(18):5829-37. PubMed ID: 14522906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of p53 protein family in gastrointestinal malignancies.
    Zaika AI; El-Rifai W
    Cell Death Differ; 2006 Jun; 13(6):935-40. PubMed ID: 16557273
    [No Abstract]   [Full Text] [Related]  

  • 14. p73 and p63 regulate the expression of fibroblast growth factor receptor 3.
    Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
    Venkatanarayan A; Raulji P; Norton W; Flores ER
    Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
    Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
    Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.